Ibogaine – News, Research and Analysis – The Conversation

Articles on Ibogaine

Displaying all articles

Subcommittee on Veterans Affairs Chair Senator David Richards and Deputy Chair Senator Pierre-Hugues Boisvenu at a news conference releasing the committee’s report on the need for psychedelic-assisted therapy for veterans on Nov. 8, 2023 in Ottawa. THE CANADIAN PRESS/Adrian Wyld

December 12, 2023

Canada owes its veterans new mental health tools: Access to psychedelic therapies is overdue

Ron Shore, Queen's University, Ontario

One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.

There are some possible health issues with the drugs, including cardiovascular risks. wildpixel/iStock via Getty Images Plus

February 10, 2023

Use of psychedelics to treat PTSD, OCD, depression and chronic pain – a researcher discusses recent trials, possible risks

Jennifer Mitchell, University of California, San Francisco

The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.

Scientific pursuits need to be coupled with a humanist tradition — to highlight not just how psychedelics work, but why that matters. (Shutterstock)

August 15, 2018

The real promise of LSD, MDMA and mushrooms for medical science

Erika Dyck, University of Saskatchewan

Once associated with mind-control experiments and counter-cultural defiance, psychedelics now show great promise for mental health treatments and may prompt a re-evaluation of the scientific method.

Top contributors

Erika Dyck
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
Jennifer Mitchell
Professor of Neurology, University of California, San Francisco
Ron Shore
Research Scientist, Queen's Health Sciences and Assistant Professor, Department of Psychiatry, Queen's University, Ontario

Articles on Ibogaine

Displaying all articles

Related Topics

Top contributors

Links